Does FUTIBATINIB Cause Therapy interrupted? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapy interrupted have been filed in association with FUTIBATINIB (LYTGOBI). This represents 3.1% of all adverse event reports for FUTIBATINIB.
5
Reports of Therapy interrupted with FUTIBATINIB
3.1%
of all FUTIBATINIB reports
2
Deaths
4
Hospitalizations
How Dangerous Is Therapy interrupted From FUTIBATINIB?
Of the 5 reports, 2 (40.0%) resulted in death, 4 (80.0%) required hospitalization.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FUTIBATINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does FUTIBATINIB Cause?
Death (30)
Diarrhoea (29)
Hyperphosphataemia (22)
Nausea (21)
Disease progression (20)
Dry mouth (18)
Fatigue (18)
Off label use (16)
Vomiting (15)
Dry eye (13)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which FUTIBATINIB Alternatives Have Lower Therapy interrupted Risk?
FUTIBATINIB vs GABAPENTIN
FUTIBATINIB vs GABAPENTIN ENACARBIL
FUTIBATINIB vs GADAVIST
FUTIBATINIB vs GADOBENATE DIMEGLUMINE
FUTIBATINIB vs GADOBUTROL